EOVIST is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Gadoxetate Disodium.
Product ID | 50419-320_1ff9281c-b174-4ce5-8116-b281fe3d2d99 |
NDC | 50419-320 |
Product Type | Human Prescription Drug |
Proprietary Name | EOVIST |
Generic Name | Gadoxetate Disodium |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2008-07-03 |
Marketing Category | NDA / NDA |
Application Number | NDA022090 |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | GADOXETATE DISODIUM |
Active Ingredient Strength | 181 mg/mL |
Pharm Classes | Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2008-07-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022090 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-07-03 |
Marketing Category | NDA |
Application Number | NDA022090 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-07-03 |
Marketing Category | NDA |
Application Number | NDA022090 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-07-03 |
Marketing End Date | 2010-08-03 |
Marketing Category | NDA |
Application Number | NDA022090 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2008-07-03 |
Ingredient | Strength |
---|---|
GADOXETATE DISODIUM | 181.43 mg/mL |
SPL SET ID: | 6218b1e1-cbc3-4c14-bec7-528ac163a561 |
Manufacturer | |
UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EOVIST 76358237 2758129 Live/Registered |
BAYER INTELLECTUAL PROPERTY GMBH 2002-01-14 |
EOVIST 74668016 not registered Dead/Abandoned |
Schering Aktiengesellschaft 1995-05-01 |